Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
N-803, an IL-15 Superagonist Complex as Maintenance Therapy After Allogeneic Donor Stem Cell Transplant for Acute Myeloid Leukemia or Myelodysplastic Syndrome; A Phase 2 Trial.
Merino A, Brunstein CC, Shanley R, Rashid F, Wangen R, Bachanova V, Juckett M, Maakaron J, Felices M, Weisdorf D, Miller JS. Merino A, et al. Among authors: maakaron j. Transplant Cell Ther. 2024 Dec;30(12):1206.e1-1206.e12. doi: 10.1016/j.jtct.2024.09.023. Epub 2024 Oct 1. Transplant Cell Ther. 2024. PMID: 39362494 Clinical Trial.
Patients with TP53-Mutated Acute Myeloid Leukemia Receiving Intensive Induction Therapy Have Superior Outcomes Due to a Higher Rate of Salvage Therapy: A Single Institution, Retrospective Study.
Sumransub N, Steinwand GK, Cordner K, Lee Y, Cao Q, Allred J, Bachanova V, Juckett M, Eckfeldt C, Maakaron JE, Tracy SI, Ramesh V, Nelson AC, Yohe S, Sachs Z. Sumransub N, et al. Among authors: maakaron je. Cancers (Basel). 2024 Aug 7;16(16):2784. doi: 10.3390/cancers16162784. Cancers (Basel). 2024. PMID: 39199557 Free PMC article.
CD19-directed CART therapy for T-cell/histiocyte-rich large B-cell lymphoma.
Pophali PA, Fein JA, Ahn KW, Allbee-Johnson M, Ahmed N, Awan FT, Farhan S, Grover NS, Hilal T, Iqbal M, Maakaron J, Modi D, Nasrollahi E, Schachter LG, Sauter C, Hamadani M, Herrera A, Shouval R, Shadman M. Pophali PA, et al. Among authors: maakaron j. Blood Adv. 2024 Oct 22;8(20):5290-5296. doi: 10.1182/bloodadvances.2024013863. Blood Adv. 2024. PMID: 38985302 Free PMC article.
Chimeric antigen receptor T-cell infusion for large B-cell lymphoma in complete remission: a center for international blood and marrow transplant research analysis.
Wang TP, Ahn KW, Shadman M, Kaur M, Ahmed N, Bacher U, Cerny J, Chen A, Epperla N, Frigault M, Grover N, Haverkos B, Hill B, Hossain N, Iqbal M, Jain T, Krem MM, Maakaron J, Modi D, Alhaj Moustafa M, Riedell P, Savani B, Sica RA, Sureda A, Wudhikarn K, Herrera AF, Sauter C, Hamadani M, Jimenez Jimenez A. Wang TP, et al. Among authors: maakaron j. Leukemia. 2024 Jul;38(7):1564-1569. doi: 10.1038/s41375-024-02242-6. Epub 2024 May 15. Leukemia. 2024. PMID: 38750138 Free PMC article.
Validation of Nivestym compared to Neupogen: An NMDP analysis.
Maakaron J, Picotte K, Tram K, Bakken R, Oakes J, Cody M, Miller J, Devine SM, Stefanski HE. Maakaron J, et al. J Clin Apher. 2024 Feb;39(1):e22097. doi: 10.1002/jca.22097. Epub 2023 Dec 1. J Clin Apher. 2024. PMID: 38037757 No abstract available.
58 results